Meta‐Analysis of the Effect of MDR1 C3435T Polymorphism on Cyclosporine Pharmacokinetics

Authors:

Abstract
Abstract: The published data revealed conflicting results of the polymorphism of MDR1 exon 26 SNP C3435T on the pharmacokinetics of cyclosporine; thus, the aim was to conduct a meta‐analysis of significant magnitude to investigate the influence of SNP C3435T on the pharmacokinetics of cyclosporine. A literature search was conducted to locate the relevant papers by using the PubMed electronic source from 1997 and onwards. The pharmacokinetic parameters, including AUC0–4, AUC0–12, AUC0‐inf, Cmax, CL/F and trough concentration (C0), were extracted and a meta‐analysis was performed by using Stata version 9.1. A total of 14 papers concerning 1036 individuals were included in the meta‐analysis. The overall results showed no major influence of SNP C3435T on the pharmacokinetic parameters, including AUC0–4, AUC0‐inf, CL/F, Cmaxand C0, although AUC0–12was lower in subjects with CC genotype. A subanalysis by ethnic population showed that C0was lower in Caucasian individuals harbouring CC genotype. In conclusion, our meta‐analysis of available studies has thus far failed to demonstrate a definitive correlation between the SNP C3435T inMDR1gene and alterations in P‐glycoprotein function that can result in altered pharmacokinetics of cyclosporine, although it was indicated in this meta‐analysis that the carrier of CC genotype of the SNP C3435T of MDR1 had lower cyclosporine exposure presented as AUC0–12than those with at least one T allele. There seems to be ethnic differences in the relationship between the SNP C3435T of MDR1 and cyclosporine pharmacokinetics.

This publication has 40 references indexed in Scilit: